This technology describes the mechanism of action and use of compound FIN56, a specific inducer of ferroptosis.
Ferroptosis is an iron-dependent form of regulated cell death that has been implicated in various diseases such as Alzheimer’s and many types of cancer. Modulation of ferroptosis is a promising and attractive strategy for developing therapeutics for these diseases. However, mechanistic studies have been difficult due to the lack of relevant research tools for studying ferroptosis, highlighting a need for further development.
This technology describes the mechanism of action and use of FIN56, a specific inducer of ferroptosis, using a combined experimental and computational framework. FIN56 induces cell death by downregulating glutathione peroxidase 4 (GPX4) protein, a lipid-repair enzyme, and by activating squalene synthase, which is important in cholesterol biosynthesis, resulting in depletion of coenzyme Q10 and subsequent iron-dependent accumulation of lipid hydroperoxides to lethal levels. Access to specific modulators of ferroptosis with defined mechanisms will expand research models for studying ferroptosis-mediated cell death, potentially enabling the discovery and development of additional ferroptosis modulators that may catapult therapeutic innovation for various diseases.
IR CU17131, CU19380
Licensing Contact: Joan Martinez